These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 12850550)
21. Differential effects of L-deprenyl on MPP+- and MPTP-induced dopamine overflow in microdialysates of striatum and nucleus accumbens. Wu WR; Zhu ZT; Zhu XZ Life Sci; 2000 Jun; 67(3):241-50. PubMed ID: 10983868 [TBL] [Abstract][Full Text] [Related]
22. In brown Norway rats, MPP+ is accumulated in the nigrostriatal dopaminergic terminals but it is not neurotoxic: a model of natural resistance to MPTP toxicity. Zuddas A; Fascetti F; Corsini GU; Piccardi MP Exp Neurol; 1994 May; 127(1):54-61. PubMed ID: 8200437 [TBL] [Abstract][Full Text] [Related]
23. A model of chronic neurotoxicity: long-term retention of the neurotoxin 1-methyl-4-phenylpyridinium (MPP+) within catecholaminergic neurons. Johannessen JN Neurotoxicology; 1991; 12(2):285-302. PubMed ID: 1956587 [TBL] [Abstract][Full Text] [Related]
24. Studies on species sensitivity to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Part 1: Systemic administration. Giovanni A; Sieber BA; Heikkila RE; Sonsalla PK J Pharmacol Exp Ther; 1994 Sep; 270(3):1000-7. PubMed ID: 7932147 [TBL] [Abstract][Full Text] [Related]
25. Diethyldithiocarbamate potentiates the neurotoxicity of in vivo 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and of in vitro 1-methyl-4-phenylpyridinium. Miller DB; Reinhard JF; Daniels AJ; O'Callaghan JP J Neurochem; 1991 Aug; 57(2):541-9. PubMed ID: 1649252 [TBL] [Abstract][Full Text] [Related]
26. Attenuation of 1-methyl-4-phenylpyridinium (MPP+) neurotoxicity by deprenyl in organotypic canine substantia nigra cultures. Schmidt DE; Ebert MH; Lynn JC; Whetsell WO J Neural Transm (Vienna); 1997; 104(8-9):875-85. PubMed ID: 9451719 [TBL] [Abstract][Full Text] [Related]
27. Immunity of fetal mice to prenatal administration of the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Melamed E; Rosenthal J; Youdim MB J Neurochem; 1990 Oct; 55(4):1427-31. PubMed ID: 2398363 [TBL] [Abstract][Full Text] [Related]
28. Studies on the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: inhibition of NAD-linked substrate oxidation by its metabolite, 1-methyl-4-phenylpyridinium. Vyas I; Heikkila RE; Nicklas WJ J Neurochem; 1986 May; 46(5):1501-7. PubMed ID: 3485701 [TBL] [Abstract][Full Text] [Related]
29. Methamphetamine protects against MPTP neurotoxicity in C57BL mice. Sziráki I; Kardos V; Patthy M; Pátfalusi M; Budai G Eur J Pharmacol; 1994 Jan; 251(2-3):311-4. PubMed ID: 8149986 [TBL] [Abstract][Full Text] [Related]
30. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neuroblastic apoptosis in the subventricular zone is caused by 1-methy-4-phenylpiridinium (MPP(+)) converted from MPTP through MAO-B. Ito T; Suzuki K; Uchida K; Nakayama H Exp Toxicol Pathol; 2012 Nov; 64(7-8):761-5. PubMed ID: 21324658 [TBL] [Abstract][Full Text] [Related]
31. Astrocytes as a primary locus for the conversion MPTP into MPP+. Brooks WJ; Jarvis MF; Wagner GC J Neural Transm; 1989; 76(1):1-12. PubMed ID: 2785159 [TBL] [Abstract][Full Text] [Related]
32. Neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on striatal biopterin in BALB/c mice. Lee EH Neurosci Lett; 1988 Jun; 88(3):297-302. PubMed ID: 3260360 [TBL] [Abstract][Full Text] [Related]
33. MPTP, MPP+ and mitochondrial function. Nicklas WJ; Youngster SK; Kindt MV; Heikkila RE Life Sci; 1987 Feb; 40(8):721-9. PubMed ID: 3100899 [TBL] [Abstract][Full Text] [Related]
34. Mechanisms of MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity to striatal dopamine neurons in mice. Fuller RW; Hemrick-Luecke SK Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(5-6):687-90. PubMed ID: 3878976 [TBL] [Abstract][Full Text] [Related]
35. The protective effect of riluzole in the MPTP model of Parkinson's disease in mice is not due to a decrease in MPP(+) accumulation. Boireau A; Dubedat P; Bordier F; Imperato A; Moussaoui S Neuropharmacology; 2000 Apr; 39(6):1016-20. PubMed ID: 10727711 [TBL] [Abstract][Full Text] [Related]
36. Elevation of neuronal MAO-B activity in a transgenic mouse model does not increase sensitivity to the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Andersen JK; Frim DM; Isacson O; Beal MF; Breakefield XO Brain Res; 1994 Sep; 656(1):108-14. PubMed ID: 7804823 [TBL] [Abstract][Full Text] [Related]
37. Dopaminergic toxicity of rotenone and the 1-methyl-4-phenylpyridinium ion after their stereotaxic administration to rats: implication for the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity. Heikkila RE; Nicklas WJ; Vyas I; Duvoisin RC Neurosci Lett; 1985 Dec; 62(3):389-94. PubMed ID: 3912685 [TBL] [Abstract][Full Text] [Related]
38. PF 9601N [N-(2-propynyl)-2-(5-benzyloxy-indolyl) methylamine], a new MAO-B inhibitor, attenuates MPTP-induced depletion of striatal dopamine levels in C57/BL6 mice. Perez V; Unzeta M Neurochem Int; 2003 Feb; 42(3):221-9. PubMed ID: 12427476 [TBL] [Abstract][Full Text] [Related]
39. Synthetic bovine proline-rich-polypeptides generate hydroxyl radicals and fail to protect dopaminergic neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity in mice. Knaryan VH; Samantaray S; Varghese M; Srinivasan A; Galoyan AA; Mohanakumar KP Neuropeptides; 2006 Aug; 40(4):291-8. PubMed ID: 16712929 [TBL] [Abstract][Full Text] [Related]
40. Sensitive and selective liquid chromatography/tandem mass spectrometry methods for quantitative analysis of 1-methyl-4-phenyl pyridinium (MPP+) in mouse striatal tissue. Zhang MY; Kagan N; Sung ML; Zaleska MM; Monaghan M J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Oct; 874(1-2):51-6. PubMed ID: 18824419 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]